Evaxion Biotech A/S - ADR (EVAX) Stock: What Does the Chart Say Tuesday?

Evaxion Biotech A/S - ADR (EVAX) stock is up 27.08% over the past week and gets a Bullish rating from InvestorsObserver Sentiment Indicator.

Evaxion Biotech A/S - ADR has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on EVAX!

See Full EVAX Report

What is Stock Sentiment?

When making investment decisions, sentiment gives a good overview of what stocks investors currently favor. Sentiment incorporates short-term technical analysis into its score and does not encompass any fundamental analysis such as profitability of the company. This means that earnings updates and other news can greatly impact overall sentiment. Recent trends are a good indicator of current market sentiments. In its most basic form, stocks that are trending up are desirable by investors while stocks currently falling must be unattractive. InvestorsObserver's Sentimental Indicator tracks both changes in price and volume to analyze the most recent trends. Typically an increase in volume indicates ongoing trends are getting stronger, while a decrease in volume usually signals an end to the current trend. Available options can also represent current sentiments for a given stock. Since investors are able to bet on future trends of stocks using options, we consider the ratio of calls to puts when analyzing market sentiments .

What's Happening With EVAX Stock Today?

Evaxion Biotech A/S - ADR (EVAX) stock is trading at $3.05 as of 3:09 PM on Tuesday, Oct 4, a gain of $0.43, or 16.41% from the previous closing price of $2.62. The stock has traded between $2.52 and $3.10 so far today. Volume today is light. So far 335,862 shares have traded compared to average volume of 1,711,245 shares.

More About Evaxion Biotech A/S - ADR

Evaxion Biotech AS is an artificial intelligence immunology platform company. It uses proprietary AI technology, engineering expertise, and drug development know-how to simulate the human immune system and generate predictive models to identify and develop efficacious immunotherapies for patients in the global market. Its two lead product candidates are EVX-01 and EVX-02, for the treatment of various cancers. Click Here to get the full Stock Report for Evaxion Biotech A/S - ADR stock.